Evidence map›Paper›PMID 36778401›Full record

ArticleResearch square2024

FAK loss reduces BRAF

Chenxi Gao, Huaibin Ge, Shih-Fan Kuan, Chunhui Cai, Xinghua Lu, Farzad Esni, Robert Schoen, Jing Wang, Edward Chu, Jing Hu

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chenxi GaoUniversity of Pittsburgh.
Huaibin GeUniversity of Pittsburgh.
Shih-Fan KuanUniversity of Pittsburgh.
Chunhui CaiUniversity of Pittsburgh.
Xinghua LuUniversity of Pittsburgh.ORCID 0000-0002-8599-2269
Farzad EsniUniversity of Pittsburgh.ORCID 0000-0002-0342-6862
Robert SchoenUniversity of Pittsburgh.ORCID 0000-0001-7153-2766
Jing WangUPMC Hillman Cancer Center/University of Pittsburgh.ORCID 0000-0003-4343-2527
Edward ChuAlbert Einstein Cancer Center.
Jing HuUniversity of pittsburgh.
University of Pittsburgh · USAlbert Einstein College of Medicine · USUPMC Hillman Cancer Center · US

Funding

Interpretable deep learning models for translational medicine RenewalR01LM012011 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Tanner J. Freeman, XINGHUA LU · 2015 to 2026
$3.6M
Targeting PYK2 for the treatment of PDACR01CA236965 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HU, JING · 2020 to 2024
$1.8M
Chemical pancreatectomy for chronic pancreatitis and pancreatic cancerR01DK120698 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ESNI, FARZAD, GITTES, GEORGE K. · 2019 to 2022
$1.8M
Evaluation of the Effect of Autoimmunity on Acinar-Derived Insulin Producing CellsR21AI158824 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ESNI, FARZAD · 2021 to 2022
$433k
NCI NIH HHS R01 CA236965NIAID NIH HHS R21 AI158824NIDDK NIH HHS R01 DK120698NLM NIH HHS R01 LM012011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRAF mutationcarcinogenesisEGFRERKFAK

Identifiers

PMID36778401
PMCPMC9915899
OpenAlexW4318677144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.